Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
SpringTide Capital Management
AddedFeb 15, 2024
UpdatedJun 28, 2026
SpringTide Capital Management

SpringTide Capital Management

Operating

Venture capital firm investing in tomorrow's leading health tech companies.

Location
Cambridge, MA, US
Founded
2018
Firm
Compare
Portfolio
Employees
Website

Investments

Binkey
Binkey

Total Raised

$3.3M

Rounds

1

Seed$3.3MDecember 2023
Soundtrace
Soundtrace

Total Raised

$2.5M

Rounds

2

Pre-Seed$2.5MSeptember 2023
OpenLoop
OpenLoop

Total Raised

$26.6M

Rounds

5

Series A$15MMarch 2023
Series A$8MMarch 2022
Biotia
Biotia

Total Raised

$10.4M

Rounds

6

Series A$8MAugust 2022
Seed$2.4MDecember 2019
RxLive
RxLive

Total Raised

$10.5M

Rounds

8

Series A$5MJuly 2022
Marigold Health
Marigold Health

Total Raised

$21.5M

Rounds

12

Seed$6MFebruary 2022
Seed$2MSeptember 2021
Pathology Watch
Pathology Watch

Total Raised

$56.7M

Rounds

10

Series B$25MNovember 2021
Series A$5MMay 2020
Seed$2.3MApril 2019
Prolucent Health
Prolucent Health

Total Raised

$15.5M

Rounds

3

Series AJune 2021
Vigor
Vigor

Total Raised

$1.9M

Rounds

2

Seed$1MApril 2021
Intellihealth
Intellihealth

Total Raised

$8.7M

Rounds

4

SeedOctober 2020
Noteworth
Noteworth

Total Raised

$7.4M

Rounds

9

Seed$5MJuly 2020
Wellsheet
Wellsheet
Acquired Subsidiary

Total Raised

$6.1M

Rounds

3

Series A$3.8MJune 2020
Debut
Debut

Total Raised

$66.2M

Rounds

4

Seed$2.6MJanuary 2020
Superconductive
Superconductive

Total Raised

$61M

Rounds

3

SeedDecember 2019
Raydiant Oximetry
Raydiant Oximetry

Total Raised

$18.1M

Rounds

10

Series A$2MSeptember 2019
Shift Health
Shift Health
Seed

Total Raised

$150k

Rounds

2

SeedAugust 2019
Inito
Inito

Total Raised

$12.9M

Rounds

7

Seed$5MMay 2019
SendaRide
SendaRide

Total Raised

$1.7M

Rounds

3

Series A$1.7MAugust 2018
FreMon Scientific
FreMon Scientific

Total Raised

$2M

Rounds

1

Series Unknown$2MMarch 2018
Ellipsis Health
Ellipsis Health

Total Raised

$30M

Rounds

3

Seed$4MDecember 2017